Annual Fractional Exhaled Nitric Oxide Measurements and Exacerbations in Severe Asthma

References

• Global initiative for asthma [homepage on the Internet]. Fontana: Global Strategy for Asthma Management and Prevention; 2020 Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed 615, 2020.
   Google Scholar
• Robinson D, Humbert M, Buhl R, et al. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017;47(2):161–175.28036144
   PubMed Web of Science ®Google Scholar
• Konno S, Taniguchi N, Makita H, et al. Distinct phenotypes of smokers with fixed airflow limitation identified by cluster analysis of severe asthma. Ann Am Thorac Soc. 2018;15(1):33–41.28910142
   PubMed Web of Science ®Google Scholar
• American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–930.15817806
   PubMed Web of Science ®Google Scholar
• Ray A, Oriss TB, Wenzel SE. Emerging molecular phenotypes of asthma. Am J Physiol Lung Cell Mol Physiol. 2015;308(2):L130–L140.25326577
   PubMed Web of Science ®Google Scholar
• Heffler E, Carpagnano GE, Favero E, et al. Fractional exhaled nitric oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC). Multidiscip Respir Med. 2020;15(1):36.32269772
   PubMed Web of Science ®Google Scholar
• Silkoff PE, Lent AM, Busacker AA, et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol. 2005;116(6):1249–1255.16337453
   PubMed Web of Science ®Google Scholar
• Korevaar DA, Westerhof GA, Wang J, et al. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(4):290–300.25801413
   PubMed Web of Science ®Google Scholar
• Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med. 2000;162(2 Pt 1):701–706.10934109
   PubMed Web of Science ®Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–615.21885636
   PubMed Web of Science ®Google Scholar
• Price DB, Buhl R, Chan A, et al. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial. Lancet Respir Med. 2018;6(1):29–39.29108938
   PubMed Web of Science ®Google Scholar
• Kimura H, Konno S, Makita H, et al. Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up. Clin Exp Allergy. 2018;48(9):1137–1146.29781543
   PubMed Web of Science ®Google Scholar
• Kimura H, Konno S, Nakamaru Y, et al. Sinus computed tomographic findings in adult smokers and nonsmokers with asthma. Analysis of clinical indices and biomarkers. Ann Am Thorac Soc. 2017;14(3):332–341.28029801
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med. 2000;162(6):2341–2351.11112161
   PubMedGoogle Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373.24337046
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458.23208313
   PubMed Web of Science ®Google Scholar
• Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001;164(5):738–743.11549525
   PubMed Web of Science ®Google Scholar
• Roberts G, Hurley C, Bush A, Lack G. Longitudinal study of grass pollen exposure, symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma. Thorax. 2004;59(9):752–756.15333850
   PubMed Web of Science ®Google Scholar
• Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med. 2005;172(7):831–836.15976380
   PubMed Web of Science ®Google Scholar
• Smith AD, Cowan JO, Brassett KP, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med. 2005;172(4):453–459.15901605
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1996;153(1):454–457.8542158
   PubMed Web of Science ®Google Scholar
• McGrath KW, Icitovic N, Boushey HA, et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med. 2012;185(6):612–619.22268133
   PubMed Web of Science ®Google Scholar
• van der Valk RJ, Baraldi E, Stern G, Frey U, de Jongste JC. Daily exhaled nitric oxide measurements and asthma exacerbations in children. Allergy. 2012;67(2):265–271.21999328
   PubMed Web of Science ®Google Scholar
• Saito J, Gibeon D, Macedo P, Menzies-Gow A, Bhavsar PK, Chung KF. Domiciliary diurnal variation of exhaled nitric oxide fraction for asthma control. Eur Respir J. 2014;43(2):474–484.23949962
   PubMed Web of Science ®Google Scholar
• Ekroos H, Tuominen J, Sovijarvi AR. Exhaled nitric oxide and its long-term variation in healthy non-smoking subjects. Clin Physiol. 2000;20(6):434–439.11100390
   PubMedGoogle Scholar
• de Laurentiis G, Maniscalco M, Cianciulli F, et al. Exhaled nitric oxide monitoring in COPD using a portable analyzer. Pulm Pharmacol Ther. 2008;21(4):689–693.18547853
   PubMed Web of Science ®Google Scholar
• Antus B, Csiszer E, Czebe K, Horvath I. Pulmonary infections increase exhaled nitric oxide in lung transplant recipients: a longitudinal study. Clin Transplant. 2005;19(3):377–382.15877802
   PubMed Web of Science ®Google Scholar
• Stern G, de Jongste J, van der Valk R, et al. Fluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children. J Allergy Clin Immunol. 2011;128(2):293–300.21489612
   PubMed Web of Science ®Google Scholar
• Sinha A, Lutter R, Xu B, et al. Loss of adaptive capacity in asthmatic patients revealed by biomarker fluctuation dynamics after rhinovirus challenge. Elife. 2019;8:e47969.31687927
   PubMed Web of Science ®Google Scholar
• Shome GP, Starnes JD 3rd, Shearer M, et al. Exhaled nitric oxide in asthma: variability, relation to asthma severity, and peripheral blood lymphocyte cytokine expression. J Asthma. 2006;43(2):95–99.16517424
   PubMed Web of Science ®Google Scholar